<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title28.html">
                                    Title 28
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/28CFR0.html">Part 0
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  0.104  Redelegation of authority.
                            </h3>
                            <p class="depth0">The Administrator of the Drug Enforcement Administration is  authorized to redelegate to any of his subordinates or any of the  officers or employees of the Immigration and Naturalization Service any  of the powers and functions vested in him by this subpart R.  [Order 1146-86, 51 FR 30485, Aug. 27, 1986]</p><p class="depth0">Sec. Appendix to Subpart R of Part 0--Redelegation of Functions</p><p class="depth0">Section 1. Scope of authority. The authority delegated by this order  is applicable to all officers and employees of the Drug Enforcement  Administration (DEA) and Federal Bureau of Investigation (FBI).</p><p class="depth0">Sec. 2. Supervisors. All Special Agents-in-Charge of the DEA and the  FBI are authorized to conduct enforcement hearings under 21 U.S.C. 883,  and to take custody of seized property under 21 U.S.C. 881. All Special  Agents-in-Charge of the DEA and the FBI, the DEA Deputy Administrator,  Assistant Administrators and Office Heads, and the FBI Executive  Assistant Directors, Assistant Directors, Deputy Assistant Directors,  and Section Chiefs, are authorized to release information pursuant to 28  CFR 0.103(a)(1) and (2) that is obtained by the DEA and the FBI, and to  authorize the testimony of DEA and FBI officials in response to  prosecution subpoenas or demands under 28 CFR 0.103(a)(3). All DEA  Laboratory Directors are authorized to release information pursuant to  28 CFR 0.103(a)(1) and (2) that is obtained by a DEA laboratory, and to  authorize the testimony of DEA laboratory personnel in response to  prosecution subpoenas or demands under 28 CFR 0.103(a)(3). All DEA  Special Agents-in-Charge are authorized to take custody of, and make  disposition of, controlled substances seized pursuant to 21 U.S.C.  824(g).</p><p class="depth0"><em>(a)</em> All DEA criminal investigators  (series 1811 under Office of Personnel Management regulations) and  special agents of the FBI are authorized to exercise all of the powers  of enforcement personnel granted by 21 U.S.C. 876, 878, and 879; to  serve subpoenas, administer oaths, examine witnesses, and receive  evidence under 21 U.S.C. 875; to execute administrative inspection  warrants under 21 U.S.C. 880; and to seize property under 21 U.S.C. 881  and 21 CFR 1316.71 et seq.</p><p class="depth0"><em>(b)</em> All DEA Diversion Investigators (series 1801 under Office of  Personnel Management regulations) are authorized to administer oaths and  serve subpoenas under 21 U.S.C. 875 and 876; to conduct administrative  inspections and execute administrative inspection warrants under 21  U.S.C. 878(2) and 880; to seize property incident to compliance and  registration inspections and investigations under 21 U.S.C. 881; and to  seize or place controlled substances under seal pursuant to 21 U.S.C.  824.</p><p class="depth0"><em>(a)</em> The Chief Inspector of the DEA;  the Deputy Chief Inspectors and Associate Deputy Chief Inspectors of the  Office of Inspections and the Office of Professional Responsibility of  the DEA; all Special Agents-in-Charge of the DEA and the FBI; DEA  Inspectors assigned to the Inspection Division; DEA Associate Special  Agents-in-Charge; DEA and FBI Assistant Special Agents-in-Charge; DEA  Resident Agents-in-Charge; DEA Diversion Program Managers; FBI  Supervisory Senior Resident Agents; DEA Special Agent Group Supervisors;  those FBI Special Agent Squad Supervisors who have management  responsibility over Organized Crime/Drug Program Investigations; and DEA  Regional Directors, Assistant Regional Directors, and Country  Attach[eacute]s, are authorized to sign and issue subpoenas with respect  to controlled substances, listed chemicals, tableting machines or  encapsulating machines under 21 U.S.C. 875 and 876 in regard to matters  within their respective jurisdictions.</p><p class="depth0"><em>(b)</em> The Administrative Law Judge of DEA is authorized to sign and  issue subpoenas to compel the attendance of witnesses and the production  of documents and materials to the extent necessary to conduct  administrative hearings pending before him.</p><p class="depth0">Sec. 5. Legal functions. The Chief Counsel and the Director of DEA's  Mid-Atlantic Laboratory are authorized to execute any certification  required to authenticate any documents pursuant to 28 CFR 0.146. The  Chief Counsel is also authorized to adjust, determine, compromise, and  settle any claims involving the Drug Enforcement Administration under 28  U.S.C. 2672 relating to tort claims where the amount of the proposed  adjustment, compromise, settlement or award does not exceed $2,500; to  formulate and coordinate the proceedings relating to the conduct of  hearings under 21 U.S.C. 875, including the signing and issuance of  subpoenas,   examining of witnesses, and receiving evidence; to adjust, determine,  compromise and settle any tort claims when such claims arise in foreign  countries in connection with DEA operations abroad, and to conduct  enforcement hearings under 21 U.S.C. 883. The Forfeiture Counsel of the  DEA is authorized to exercise all necessary functions with respect to  decisions on petitions under 19 U.S.C. 1618 for remission or mitigation  of forfeitures incurred under 21 U.S.C. 881.</p><p class="depth0">Sec. 6. Import and export permits. The Deputy Assistant  Administrator of the DEA Office of Diversion Control, the Deputy  Director of the DEA Office of Diversion Control, the Chief of the Drug  Operations Section of the DEA Office of Diversion Control, and the Chief  of the International Drug Unit of the Drug Operations Section of the DEA  Office of Diversion Control are authorized to perform all and any  functions with respect to the issuance of importation and exportation  permits for controlled substances under 21 U.S.C. 952 and 953, and all  functions in regard to transshipments and intransit shipments of  controlled substances under 21 U.S.C. 954.</p><p class="depth0">Sec. 7. Promulgation of regulations. The Deputy Assistant  Administrator of the DEA Office of Diversion Control is authorized to  exercise all necessary functions with respect to the promulgation and  implementation of the following regulations published in chapter II,  title 21, Code of Federal Regulations:</p><p class="depth0"><em>(a)</em> Part 1301, incident to the registration of manufacturers,  distributors, and dispensers of controlled substances, except that final  orders in connection with suspension, denial or revocation of  registration shall be made by the Deputy Administrator of DEA.</p><p class="depth0"><em>(b)</em> Part 1302 relating to labelling and packaging requirements for  controlled substances.</p><p class="depth0"><em>(c)</em> Part 1304 relating to records and reports of registrants.</p><p class="depth0"><em>(d)</em> Part 1305 relating to order forms.</p><p class="depth0"><em>(e)</em> Part 1306 relating to prescriptions, except provisions relating  to dispensing of narcotic drugs for maintenance purposes.</p><p class="depth0"><em>(f)</em> Part 1307, title 21, Code of Federal Regulations, relating to  miscellaneous provisions, except Sec.  1307.31 concerning special exempt  persons.</p><p class="depth0"><em>(g)</em> The following sections of part 1308: Sec. Sec.  1308.21 and  1308.22 relating to excluded nonnarcotic substances; Sec. Sec.  1308.23  and 1308.24 relating to exempt chemical preparations; Sec. Sec.  1308.25  and 1308.26 relating to excluded veterinary anabolic steroid implant  products; Sec. Sec.  1308.31 and 1308.32 relating to exempted  prescription products; and Sec. Sec.  1308.33 and 1308.34 relating to  exempt anabolic steroid products, except that any final order following  a contested proposed rulemaking shall be issued by the Deputy  Administrator of DEA.</p><p class="depth0"><em>(h)</em> Part 1309, incident to the registration of manufacturers,  distributors, importers and exporters of List I chemicals, except that  final orders in connection with suspension, denial or revocation of  registration shall be made by the Deputy Administrator of DEA.</p><p class="depth0"><em>(i)</em> Part 1310, relating to records, reports and identification of  parties to transactions in listed chemicals and certain machinery, but  not including the authority to add and delete listed chemicals pursuant  to 21 CFR 1310.02.</p><p class="depth0"><em>(j)</em> Part 1311 relating to registration of importers and exporters of  controlled substances, except that final orders in connection with  suspension, denial or revocation of registration shall be made by the  Deputy Administrator of DEA.</p><p class="depth0"><em>(k)</em> Part 1312 relating to importation and exportation of controlled  substances, except that all final orders following a contested proposed  rulemaking regarding the denial of an application for an import, export  or transshipment permit shall be made by the Deputy Administrator of  DEA.</p><p class="depth0"><em>(l)</em> Part 1313, relating to the importation and exportation of  precursors and essential chemicals, but not including the authority to  suspend shipments under 21 CFR 1313.41.</p><p class="depth0"><em>(m)</em> Part 1314, incident to the retail sale of scheduled listed  chemical products by regulated sellers and distributors required to  submit reports under section 310(b)(3) of the Act (21 U.S.C. 830(b)(3)),  except that final orders in connection with suspension or revocation of  the regulated seller's or mail order distributor's right to sell  scheduled listed chemical products shall be made by the Deputy  Administrator of the Drug Enforcement Administration.</p><p class="depth0">Sec. 8. Financial functions. The Controller of the DEA is authorized  to settle any employee claims filed under the Military Personnel and  Civilian Employees' Claims Act in an amount not to exceed $25,000.</p><p class="depth0">Sec. 9. Chemical Diversion Act functions. The Chief of Operations of  the DEA, Operations Division, is authorized to furnish, or cause to be  furnished, descriptions of persons with whom regulated transactions may  not be completed without prior approval of the DEA; to approve such  transactions pursuant to 21 U.S.C. 830(b) and 21 CFR 1310.05(b); and to  approve or disapprove regular customer or regular importer status under  21 U.S.C. 971 and 21 CFR 1313.15 and 1313.24.</p><p class="depth0">Sec. 10. Deputization of State and Local Law Enforcement Officers.  The Chief, Investigative Support Section, Office of Operations  Management, Operations Division, is authorized to exercise all necessary  functions with respect to the deputization of state and local law  enforcement officers as Task Force Officers of DEA pursuant to 21 U.S.C.  878(a).</p><p class="depth0">Sec. 11. Cross-Designation of Federal Law Enforcement Officers. The  Chief, Investigative Support Section, Office of Operations Management,  Operations Division is authorized   to exercise all necessary functions with respect to the cross- designation of Federal law enforcement officers to undertake title 21  drug investigations under supervision of the DEA pursuant to 21 U.S.C.  873(b).</p><p class="depth0">Sec. 12. All other functions. The Deputy Administrator is authorized  to exercise all necessary functions under 21 CFR parts 1300 through  1316, except those functions otherwise delegated within this subpart.  This will include functions which may be vested in the Administrator in  subsequent amendments to 21 CFR parts 1300 through 1316 and not  otherwise specifically assigned or reserved by him.  [47 FR 43370, Oct. 1, 1982]</p><p class="depth0">Editorial Note: For Federal Register citations affecting the  appendix to subpart R of part 0, see the List of CFR Sections Affected,  which appears in the Finding Aids section of the printed volume and at  www.fdsys.gov.</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
